Rhino Labs, Inc. — Form D/A

Rhino Labs, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2023-08-16. The offering totals $8.0M, of which $7.0M was reported sold. Industry: Other Banking and Financial Services.

Offering

• Filed: 2023-08-16
• Form: D/A
• Accession: 0001706048-23-000003
• Industry: Other Banking and Financial Services
• Exemptions: 06b
• Total offering: $8.0M
• Amount sold: $7.0M
• Remaining: $1.0M
• Investors: 4
• Date of first sale: 2023-05-30
• Revenue range: Decline to Disclose
• SEC file number: 021-483458

Issuer

• Name: Rhino Labs, Inc.
• CIK: 0001706048
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2017
• Address: 99 WALL ST #1504, NEW YORK, NY, 10005
• Phone: 914-623-8455

Officers, directors & promoters (20)

Other filings by this issuer (13)

More

• CIK 1706048 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search